SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-027893
Filing Date
2022-08-04
Accepted
2022-08-04 06:01:54
Documents
56
Period of Report
2022-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 2Q22 agle-8k_20220804.htm   iXBRL 8-K 42827
2 EX-99.1 AGLE 2Q22 ER agle-ex991_120.htm EX-99.1 232100
3 EX-99.2 AGLE CORP PRES agle-ex992_121.htm EX-99.2 46496
4 GRAPHIC slide-qqejkppni1p.jpg GRAPHIC 190423
5 GRAPHIC slide-4jpq4wi43yy.jpg GRAPHIC 195657
6 GRAPHIC slide-tfc21yzqye2.jpg GRAPHIC 145620
7 GRAPHIC slide-a3usixjpir5.jpg GRAPHIC 161096
8 GRAPHIC slide-r5uaeybgguq.jpg GRAPHIC 219360
9 GRAPHIC slide-1mhas3ckbpv.jpg GRAPHIC 167146
10 GRAPHIC slide-mkbsvcnjiw5.jpg GRAPHIC 214233
11 GRAPHIC slide-nw2jo2m3obz.jpg GRAPHIC 114185
12 GRAPHIC slide-d0mo0mhdune.jpg GRAPHIC 177746
13 GRAPHIC slide-3urg1ipzrow.jpg GRAPHIC 191416
14 GRAPHIC slide-fiunjgddluj.jpg GRAPHIC 76263
15 GRAPHIC slide-u51phz1xyfi.jpg GRAPHIC 216657
16 GRAPHIC ggsvgyuavpwk000001.jpg GRAPHIC 12575
17 GRAPHIC slide-4jcunaqztcj.jpg GRAPHIC 154602
18 GRAPHIC slide-jklmm45w4oy.jpg GRAPHIC 246372
19 GRAPHIC slide-jwnxgee13uv.jpg GRAPHIC 62590
20 GRAPHIC slide-1r0fh5wjsrp.jpg GRAPHIC 138771
21 GRAPHIC slide-oaehffja0xy.jpg GRAPHIC 230885
22 GRAPHIC slide-wflivgkcw02.jpg GRAPHIC 239216
23 GRAPHIC slide-xdwsdafkw43.jpg GRAPHIC 141020
24 GRAPHIC slide-bju3tueap3p.jpg GRAPHIC 248739
25 GRAPHIC slide-nils4ce0jwd.jpg GRAPHIC 169982
26 GRAPHIC slide-zposcrsoxt0.jpg GRAPHIC 156572
27 GRAPHIC slide-4gbomzx2yo2.jpg GRAPHIC 171024
28 GRAPHIC slide-kqfsldkkquv.jpg GRAPHIC 159534
29 GRAPHIC slide-cid0hzikncn.jpg GRAPHIC 190663
30 GRAPHIC slide-oswmdvj5mar.jpg GRAPHIC 267100
31 GRAPHIC slide-1nppnhzxxef.jpg GRAPHIC 223388
32 GRAPHIC slide-otbd1dj0q1v.jpg GRAPHIC 182010
33 GRAPHIC slide-vmd1oypaonq.jpg GRAPHIC 198502
34 GRAPHIC slide-3o40btbyicf.jpg GRAPHIC 200957
35 GRAPHIC slide-xfqsrd0bbsl.jpg GRAPHIC 165215
36 GRAPHIC slide-rxnjqfxsvxd.jpg GRAPHIC 182075
37 GRAPHIC slide-lsahodizzka.jpg GRAPHIC 209357
38 GRAPHIC slide-guvrcuncnat.jpg GRAPHIC 211762
39 GRAPHIC slide-ynx0ejjebhy.jpg GRAPHIC 256982
40 GRAPHIC slide-zpde1idijre.jpg GRAPHIC 249754
41 GRAPHIC slide-pwxm4zhzxhk.jpg GRAPHIC 171392
42 GRAPHIC slide-0enfblb4v5u.jpg GRAPHIC 165906
43 GRAPHIC slide-qgt3uf3cpjg.jpg GRAPHIC 80754
44 GRAPHIC slide-m3t05unnccu.jpg GRAPHIC 144902
45 GRAPHIC slide-mveae5d4u4i.jpg GRAPHIC 401555
  Complete submission text file 0001564590-22-027893.txt   11099383

Data Files

Seq Description Document Type Size
46 XBRL TAXONOMY EXTENSION SCHEMA agle-20220804.xsd EX-101.SCH 5577
47 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20220804_lab.xml EX-101.LAB 19320
48 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20220804_pre.xml EX-101.PRE 11477
50 EXTRACTED XBRL INSTANCE DOCUMENT agle-8k_20220804_htm.xml XML 3556
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 221134432
SIC: 2834 Pharmaceutical Preparations